Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Startups & Unicorns companies in Levodopa
by Most Patent Filings in the world in 2022

The Levodopa top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Levodopa Startups & Unicorns in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
l-DOPA, also known as levodopa and l-3,4-dihydroxyphenylalanine, is an amino acid that is made and used as part of the normal biology of humans, as well as some animals and plants. Humans, as well as a portion of the other animals that utilize l-DOPA in their biology, make it via biosynthesis from the amino acid l-tyrosine. l-DOPA is the precursor to the neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), which are collectively known as catecholamines. Furthermore, l-DOPA itself mediates neurotrophic factor release by the brain and CNS. l-DOPA can be manufactured and in its pure form is sold as a psychoactive drug with the INN levodopa; trade names include Sinemet, Pharmacopa, Atamet, Stalevo, Madopar, and Prolopa. As a drug, it is used in the clinical treatment of Parkinson's disease and dopamine-responsive dystonia.
#
Company Name
Region
Tech Topics
Total
1
Genève, Switzerland
Health care,Apomorphine,Safinamide,
...[+1]
Patent: 17
2
United Kingdom
Pharmacy and Therapeutics,Biology
Patent: 9
3
Patent: 8
4
Jerusalem, Israel
Drug,Health care,Zolmitriptan,
...[+2]
Patent: 3
5
Ningbo Meisai Biological Engineering Co. Ltd.
Zhejiang Sheng, China
Patent: 3
Page generation time: May 11 2025